Volga-M 0.3 Tablet SR

Introduction to Volga-M 0.3 Tablet SR

Volga-M 0.3 Tablet SR is prescribed to manage high blood sugar levels in individuals with type 2 diabetes mellitus.

Metformin is classified as a biguanide, that works by reducing glucose production in the liver and increasing insulin sensitivity in tissues.

Voglibose belongs to the class of medications called alpha-glucosidase inhibitors function by inhibiting enzymes in the digestive system that break down carbohydrates into simple sugars.

Inform your doctor about any existing medical conditions, allergies, or medications you are currently taking before starting this combination of drugs.

Monitor blood sugar levels regularly and attend follow-up appointments as advised by your doctor.

Patients prescribed it should adhere to their healthcare provider's recommendations regarding dosage and duration of treatment.

It is crucial to report any persistent symptoms or adverse effects promptly.

Related Faqs

Does Piorest affect liver?

Yes, Piorest may cause an increase in liver enzymes and treatment with Piorest should be stopped if liver enzymes increase. Hence, levels of liver enzymes should be periodically checked while on treatment with Piorest. Piorest should not be prescribed to patients with liver disease.

Can Piorest cause bladder cancer?

Piorest may increase the risk of bladder cancer, though it is very rare. Immediately consult your doctor if you experience blood in your urine, pain when urinating or a sudden need to urinate, during treatment with Piorest. Piorest should not be used in patients with a prior history of bladder cancer or having bladder cancer.

Can Piorest cause weight gain?

Piorest commonly causes weight gain which may be dose related. The reason for this weight gain could be fat accumulation. While, in heart failure patients it could be due to water retention in the body. Therefore, it is important to monitor weight in heart failure cases.